Literature DB >> 4139116

Effects of antigen-antibody complexes on the primary immune response in Rhesus monkeys.

W E Houston, C E Pedersen, F E Cole, R O Spertzel.   

Abstract

A model for the enhancement of the primary humoral immune response of rhesus monkeys to marginal or weakly antigenic vaccines is presented. Our procedure used the complexing of formalin-inactivated Venezuelan equine encephalomyelitis (VEE) virus vaccine with specific, homologous, immune gamma globulin (IgG) at equivalence. Equivalence was determined by combining the concentrated, isotopically labeled ((3)H) virus with various concentrations of specific Sephadex-fractionated IgG. Enhancement of VEE virus antibody response in monkeys was obtained from preparations containing a marginal concentration of antigen that was complexed at equivalence with homologous IgG as compared with antigen alone. Protection in Swiss mice closely paralleled the antibody response pattern observed in monkeys, since complexes at equivalence provided 30 to 50% greater protection against challenge than antigen alone.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4139116      PMCID: PMC422972          DOI: 10.1128/iai.10.3.437-442.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  ENHANCED ANTITOXIN RESPONSES IN IRRADIATED MICE ELICITED BY COMPLEXES OF TETANUS TOXOID AND SPECIFIC ANTIBODY.

Authors:  R D STONER; G TERRES
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

2.  A PREPARATIVE METHOD FOR THE SEPARATION OF 7S GAMMA GLOBULIN FROM HUMAN SERUM.

Authors:  J S BAUMSTARK; R J LAFFIN; W A BARDAWIL
Journal:  Arch Biochem Biophys       Date:  1964-12       Impact factor: 4.013

3.  A simplified micro double-diffusion agar precipitin technique.

Authors:  A J CROWLE
Journal:  J Lab Clin Med       Date:  1958-11

4.  A plaque neutralization method for arboviruses.

Authors:  E Earley; P H Peralta; K M Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1967-07

5.  Use of hyperimmune anti-rabies serum concentrates in experimental rabies.

Authors:  H KOPROWSKI; J VAN DER SCHEER; J BLACK
Journal:  Am J Med       Date:  1950-04       Impact factor: 4.965

6.  Chromatography of Venezuelan equine encephalomyelitis virus strains on calcium phosphate.

Authors:  C E Pedersen; D R Slocum; N H Levitt
Journal:  Appl Microbiol       Date:  1972-07

7.  Early protection in hamsters immunized with attenuated Venezuelan equine encephalomyelitis vaccine.

Authors:  F E Cole; C E Pedersen; D M Robinson
Journal:  Appl Microbiol       Date:  1972-10

8.  Antibody responses in rhesus monkeys exposed to whole-body x-irradiation.

Authors:  S L Reynolds; C P Craig; H W Whitford; J Airhart; W B Staab
Journal:  Radiat Res       Date:  1968-08       Impact factor: 2.841

9.  Immunological studies on the envelope component of Venezuelan equine encephalomyelitis virus.

Authors:  C E Pedersen; D R Slocum; G A Eddy
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

10.  Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man.

Authors:  A C Alevizatos; R W McKinney; R D Feigin
Journal:  Am J Trop Med Hyg       Date:  1967-11       Impact factor: 2.345

View more
  5 in total

1.  Autoimmune implications of immune complexes in clinical variants of hepatitis B.

Authors:  H Daugharty; K Kelley; C Moore; T Hersh
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

2.  Platelet aggregation by hepatitis B surface antigen-antibody complexes.

Authors:  H Daugharty; R Gogel
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

3.  Adjuvant effects of diethylaminoethyl-dextran.

Authors:  W E Houston; C L Crabbs; R J Kremer; J W Springer
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

4.  Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant.

Authors:  W E Houston; C L Crabbs; E L Stephen; H B Levy
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

5.  Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.

Authors:  H H Sedlacek
Journal:  Klin Wochenschr       Date:  1980-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.